ReflectivAI

Request Demo

← All insights

· 4 min read · Tony Abdelmalak

The 82/28 Credibility Gap: Why Pharma Execs Believe in Digital Engagement While HCPs Don't

A Deloitte global survey found that 82% of life sciences executives are satisfied with their current customer engagement strategies, while only 28% of HCPs feel these strategies meet their needs…

Everyone in pharma commercial leadership is talking about digital transformation. Very few are talking about who actually believes it's working.

According to Deloitte, a staggering 82% of life sciences executives are satisfied with their current customer engagement strategies, yet only 28% of HCPs feel that these strategies meet their needs effectively

That's not a small discrepancy. That's two different realities operating inside the same commercial model.

The Numbers Behind the Gap

This wasn't a hallway poll. Deloitte surveyed "over 190 HCPs and 50 pharmaceutical executives from the top 25 pharmaceutical firms," according to Deloitte's "Unlocking the Future of Customer Engagement in Pharma."

The US team found the same pattern with a different sample. "80% of pharma executives are content with their customer engagement strategies" while "35% of HCPs said that pharma's customer-facing resources met their needs," according to Deloitte US's "Customer Engagement Strategies in Pharma."

Two surveys. Two samples. Same structural mismatch.

That consistency matters. One outlier is noise. Two independent measurements landing on the same gap is a signal.

It Isn't a Channel Problem

The easy move is to blame the channel. More digital investment. More portals, more email cadences, more webinars.

I don't think that's it.

According to Deloitte, 34% of HCPs say that sales reps do not tailor their messages and are ineffective at conveying the scientific narrative. That's not a distribution problem. That's a judgment problem.

Indegene's global survey of nearly 1,000 HCPs found the same thing from a different angle. 70% feel that pharma representatives do not understand their requirements completely, according to Indegene's "Closing the widening gap between HCPs' expectations and their pharma experiences."

Understanding a requirement is a behavior. It happens in the conversation, not in the CRM afterward.

The Trust Deficit Nobody Wants to Name

Execution gaps are fixable. Trust gaps aren't, not with a training module.

Graphite Digital's survey, reported by FiercePharma, found that found 80% of consultants are skeptical of pharma content because of doubts about the cherry-picking of data and other concerns

One HCP put it plainly: If there were endpoints that weren't favorable to the drug, they may not be there, according to FiercePharma, citing the Graphite Digital survey.

That's not a complaint about messaging polish. That's a description of selective honesty. Once an HCP suspects that in one asset, they extend it to the entire relationship, including the rep in front of them.

More Content Isn't the Fix

Here's what should worry commercial leaders most. Pharma has been pouring resources into digital engagement, and HCPs are tired of it.

Indegene found that 62% are experiencing product-related promotional content fatigue, according to Indegene's "Closing the widening gap between HCPs' expectations and their pharma experiences."

Volume went up. Trust didn't follow. Fatigue did.

More engagement isn't more effective. It's just more noise, delivered on a schedule someone in marketing built a year ago.

Why the Gap Persists

Executives are measuring the wrong thing. They're satisfied because the infrastructure works: content ships, meetings happen, dashboards populate.

But infrastructure isn't judgment.

Territory design. Call planning. Message sequencing.

All of it can run perfectly and still miss the moment where an HCP decides whether to trust what they just heard. That moment doesn't show up in a CRM field. It shows up in tone, in what a rep chooses not to say, in whether the data survives a second look.

Almost nobody is measuring that moment directly. Executives measure outputs. HCPs react to something else, the judgment behind the output.

Where This Leaves Commercial Teams

I don't think the fix is another content refresh or another CRM field.

The fix starts with making judgment visible, human-led, and honest enough to survive scrutiny. That's what we're building at ReflectivAI. Signal Intelligence surfaces how reps actually notice, interpret, and respond inside real conversations, not just what they were scripted to say.

We're early. Pilot and roadmap work, not a finished system.

But the 82/28 gap won't close through more dashboards. It will close when someone measures the conversation itself, the part that currently happens off the record and gets judged by the HCP alone.

So here's the real question for commercial leaders: Would you trust what your reps say in the room if an HCP were recording it?

Sources